Livongo Members with Type 2 Diabetes Will Get Voluntis’ Insulia
Livongo Health and Voluntis announced today a partnership to offer the Livongo for Diabetes program with Voluntis’ Insulia®, an FDA-cleared medical device and app that provides basal insulin dose recommendations for people with Type 2 diabetes. Livongo is the leading consumer digital health company focused on empowering people with chronic conditions to live better and healthier lives and Voluntis innovates healthcare by embedding connectivity in therapeutics and medical intelligence in software. With this alliance, Livongo and Voluntis will create an expanded solution that aims to improve medication adherence and optimization by offering better information personalized to Livongo members. ... |